首页 > 最新文献

Heart rhythm最新文献

英文 中文
Prediction of sudden cardiac death using artificial intelligence: Current status and future directions. 利用人工智能预测心脏性猝死:现状与未来方向。
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-06 DOI: 10.1016/j.hrthm.2024.09.003
Maarten Zh Kolk, Samuel Ruipérez-Campillo, Arthur Am Wilde, Reinoud E Knops, Sanjiv M Narayan, Fleur Vy Tjong

Sudden cardiac death (SCD) remains a pressing health issue, affecting hundreds of thousands each year globally. The heterogeneity among SCD victims, ranging from individuals with severe heart failure to seemingly healthy individuals, poses a significant challenge for effective risk assessment. Conventional risk stratification, which primarily relies on left ventricular ejection fraction, has resulted in only modest efficacy of implantable cardioverter-defibrillators (ICD) for SCD prevention. In response, artificial intelligence (AI) holds promise for personalised SCD risk prediction and tailoring preventive strategies to the unique profiles of individual patients. Machine and deep learning algorithms have the capability to learn intricate non-linear patterns between complex data and defined endpoints, and leverage these to identify subtle indicators and predictors of SCD that may not be apparent through traditional statistical analysis. However, despite the potential of AI to improve SCD risk stratification, there are important limitations that need to be addressed. We aim to provide an overview of the current state-of-the-art of AI prediction models for SCD, highlight the opportunities for these models in clinical practice, and identify the key challenges hindering widespread adoption.

心脏性猝死(SCD)仍然是一个紧迫的健康问题,每年影响全球数十万人。SCD 患者之间存在异质性,既有严重心力衰竭的患者,也有看似健康的患者,这给有效的风险评估带来了巨大挑战。传统的风险分层主要依赖于左心室射血分数,而植入式心律转复除颤器(ICD)在预防 SCD 方面的疗效甚微。对此,人工智能(AI)有望实现个性化的 SCD 风险预测,并根据个体患者的独特情况量身定制预防策略。机器学习和深度学习算法有能力学习复杂数据和定义终点之间错综复杂的非线性模式,并利用这些模式来识别传统统计分析可能无法发现的 SCD 细微指标和预测因素。然而,尽管人工智能具有改善 SCD 风险分层的潜力,但仍有一些重要的局限性需要解决。我们旨在概述当前 SCD 人工智能预测模型的最新进展,强调这些模型在临床实践中的机遇,并找出阻碍其广泛应用的主要挑战。
{"title":"Prediction of sudden cardiac death using artificial intelligence: Current status and future directions.","authors":"Maarten Zh Kolk, Samuel Ruipérez-Campillo, Arthur Am Wilde, Reinoud E Knops, Sanjiv M Narayan, Fleur Vy Tjong","doi":"10.1016/j.hrthm.2024.09.003","DOIUrl":"https://doi.org/10.1016/j.hrthm.2024.09.003","url":null,"abstract":"<p><p>Sudden cardiac death (SCD) remains a pressing health issue, affecting hundreds of thousands each year globally. The heterogeneity among SCD victims, ranging from individuals with severe heart failure to seemingly healthy individuals, poses a significant challenge for effective risk assessment. Conventional risk stratification, which primarily relies on left ventricular ejection fraction, has resulted in only modest efficacy of implantable cardioverter-defibrillators (ICD) for SCD prevention. In response, artificial intelligence (AI) holds promise for personalised SCD risk prediction and tailoring preventive strategies to the unique profiles of individual patients. Machine and deep learning algorithms have the capability to learn intricate non-linear patterns between complex data and defined endpoints, and leverage these to identify subtle indicators and predictors of SCD that may not be apparent through traditional statistical analysis. However, despite the potential of AI to improve SCD risk stratification, there are important limitations that need to be addressed. We aim to provide an overview of the current state-of-the-art of AI prediction models for SCD, highlight the opportunities for these models in clinical practice, and identify the key challenges hindering widespread adoption.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of SGLT2 Inhibitors on the Outcomes of Patients with Cardiac Arrythmias and Transthyretin Cardiac Amyloidosis. SGLT2 抑制剂对心律失常和转甲状腺素心脏淀粉样变性患者预后的影响。
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-06 DOI: 10.1016/j.hrthm.2024.09.002
Aravinthasamy Sivamurugan, Stefano H Byer, Udhayvir S Grewal, Paari Dominic
{"title":"Impact of SGLT2 Inhibitors on the Outcomes of Patients with Cardiac Arrythmias and Transthyretin Cardiac Amyloidosis.","authors":"Aravinthasamy Sivamurugan, Stefano H Byer, Udhayvir S Grewal, Paari Dominic","doi":"10.1016/j.hrthm.2024.09.002","DOIUrl":"https://doi.org/10.1016/j.hrthm.2024.09.002","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Procedural and Long-Term Outcomes of Tunneled Transvenous Leads. 隧道式经静脉导联的手术和长期疗效
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-06 DOI: 10.1016/j.hrthm.2024.08.063
Wissam Mekary, Rand Ibrahim, Stacy Westerman, Anand Shah, Neal K Bhatia, Faisal M Merchant, Mikhael F El-Chami

Background: Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIED). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long term outcomes remain unclear with this technique.

Objective: We sought to assess outcomes of tunneled transvenous leads.

Methods: We retrospectively identified all patients who underwent transvenous CIED lead tunneling to a contralateral pocket at our institution between 2014 and 2024. Clinical characteristics, indications for lead implant, post-operative complications and long-term outcomes were collected.

Results: We identified 27 patients underwent transvenous lead tunneling at our institution. Most patients were males (74%) with an average age of 68.8 ± 18.3 years old. Most patients had non-ischemic cardiomyopathy (59%) with an average ejection fraction of 29.3 ± 11.3 %. The tunneled leads were coronary sinus leads (20), followed by defibrillator leads (5) and RV pacing leads (2). Implants were primarily for device upgrade (18), lead revisions (8), or de-novo lead placement (1). No post-operative complications were seen. Patients were followed for an average of 2.2 ± 1.4 years. One tunneled defibrillator lead (3.7%) had low shock impedance 3 years after implant which was monitored and did not require an intervention.

Conclusion: In patients with ipsilateral venous occlusion, contralateral lead tunneling appears to be an effective and safe approach to manage CIED patients with occluded ipsilateral subclavian veins.

背景:与导联相关的静脉狭窄和闭塞会使心脏植入式电子设备(CIED)患者的经静脉导联插入或更换复杂化。一种可能的解决方案是将导线从对侧血管穿至同侧发生器。这种技术的手术并发症和长期疗效仍不明确:我们试图评估隧道式经静脉导联的疗效:方法:我们回顾性地确定了 2014 年至 2024 年期间在本机构接受经静脉 CIED 导联隧道至对侧腔的所有患者。收集临床特征、导联植入适应症、术后并发症和长期疗效:我们发现有 27 名患者在本院接受了经静脉导联隧道植入术。大多数患者为男性(74%),平均年龄(68.8 ± 18.3)岁。大多数患者患有非缺血性心肌病(59%),平均射血分数为(29.3 ± 11.3)%。隧道导联是冠状窦导联(20 个),其次是除颤器导联(5 个)和 RV 起搏导联(2 个)。植入导联主要是为了设备升级(18 例)、导联翻新(8 例)或重新植入导联(1 例)。术后未出现并发症。患者平均接受了 2.2 ± 1.4 年的随访。有一个隧道式除颤器导联(3.7%)在植入3年后出现低冲击阻抗,经监测后无需干预:结论:对于同侧静脉闭塞的患者,对侧导联隧道植入术似乎是治疗同侧锁骨下静脉闭塞的 CIED 患者的一种有效而安全的方法。
{"title":"Procedural and Long-Term Outcomes of Tunneled Transvenous Leads.","authors":"Wissam Mekary, Rand Ibrahim, Stacy Westerman, Anand Shah, Neal K Bhatia, Faisal M Merchant, Mikhael F El-Chami","doi":"10.1016/j.hrthm.2024.08.063","DOIUrl":"https://doi.org/10.1016/j.hrthm.2024.08.063","url":null,"abstract":"<p><strong>Background: </strong>Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIED). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long term outcomes remain unclear with this technique.</p><p><strong>Objective: </strong>We sought to assess outcomes of tunneled transvenous leads.</p><p><strong>Methods: </strong>We retrospectively identified all patients who underwent transvenous CIED lead tunneling to a contralateral pocket at our institution between 2014 and 2024. Clinical characteristics, indications for lead implant, post-operative complications and long-term outcomes were collected.</p><p><strong>Results: </strong>We identified 27 patients underwent transvenous lead tunneling at our institution. Most patients were males (74%) with an average age of 68.8 ± 18.3 years old. Most patients had non-ischemic cardiomyopathy (59%) with an average ejection fraction of 29.3 ± 11.3 %. The tunneled leads were coronary sinus leads (20), followed by defibrillator leads (5) and RV pacing leads (2). Implants were primarily for device upgrade (18), lead revisions (8), or de-novo lead placement (1). No post-operative complications were seen. Patients were followed for an average of 2.2 ± 1.4 years. One tunneled defibrillator lead (3.7%) had low shock impedance 3 years after implant which was monitored and did not require an intervention.</p><p><strong>Conclusion: </strong>In patients with ipsilateral venous occlusion, contralateral lead tunneling appears to be an effective and safe approach to manage CIED patients with occluded ipsilateral subclavian veins.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a predictive model for atrial fibrillation recurrence post-catheter ablation in non-valvular atrial fibrillation patients based on hemodynamic parameters. 基于血液动力学参数,开发并验证非瓣膜性心房颤动患者导管消融术后心房颤动复发的预测模型。
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-03 DOI: 10.1016/j.hrthm.2024.08.058
Decai Zeng, Shuai Chang, Xiaofeng Zhang, Yanfen Zhong, Yongzhi Cai, Tongtong Huang, Ji Wu

Background: The influence of hemodynamic parameters on the recurrence of atrial fibrillation (AF) following catheter ablation is not well known, and it remains unclear whether a nomogram combining risk factors and hemodynamic parameters improves prediction accuracy.

Objective: This study aimed to develop a nomogram based on echocardiographic hemodynamic parameters for predicting AF recurrence following catheter ablation in non-valvular atrial fibrillation (NVAF).

Methods: A total of 380 consecutive NVAF patients undergoing AF catheter ablation treatment were prospectively collected. Patients were divided into training and validation cohorts at a 7:3 ratio. The follow-up duration averaged 9 months with a median of 12 months, during which 132 patients (34.7%) experienced a recurrence of AF.

Results: LASSO regression and Cox regression analyses identified four significant predictors of AF recurrence: persistent AF (HR=1.63, 95% CI=1.02∼2.61, P=0.041), the systolic/diastolic (S/D) ratio (HR=0.50, 95% CI=0.30∼0.84, P=0.009), left atrial acceleration factor α (HR=1.31, 95% CI=1.02∼1.68, P=0.032), and left atrial appendage peak emptying flow velocity (HR=0.98, 95% CI=0.97∼0.99, P=0.004). Based on these four variables, a predictive nomogram was constructed. The nomogram demonstrated C-indexes of 0.664 and 0.728 for predicting 1-year and 2-year AF recurrence, respectively, in the validation cohort. The Kaplan-Meier survival analysis indicated that a Nomo-score greater than 128 was associated with a higher risk of AF recurrence.

Conclusion: Hemodynamic parameters may offer valuable insight in predicting AF recurrence following catheter ablation. Our study successfully developed a reliable nomogram based on echocardiographic hemodynamic parameters to estimate the risk of AF recurrence after catheter ablation in NVAF patients.

背景:血液动力学参数对导管消融术后心房颤动(房颤)复发的影响尚不十分清楚,将风险因素和血液动力学参数相结合的提名图是否能提高预测的准确性仍不明确:本研究旨在开发一种基于超声心动图血液动力学参数的提名图,用于预测非瓣膜性心房颤动(NVAF)导管消融术后的房颤复发:方法:前瞻性地收集了380例连续接受房颤导管消融治疗的非瓣膜性心房颤动患者。患者按 7:3 的比例分为训练组和验证组。随访时间平均为 9 个月,中位数为 12 个月,期间有 132 名患者(34.7%)出现房颤复发:结果:LASSO 回归和 Cox 回归分析确定了房颤复发的四个重要预测因素:持续性房颤(HR=1.63,95% CI=1.02∼2.61,P=0.041)、收缩压/舒张压(S/D)比值(HR=0.50,95% CI=0.30∼0.84,P=0.009)、左房加速因子α(HR=1.31,95% CI=1.02∼1.68,P=0.032)和左房阑尾峰值排空流速(HR=0.98,95% CI=0.97∼0.99,P=0.004)。根据这四个变量,构建了一个预测提名图。在验证队列中,该提名图预测 1 年和 2 年房颤复发的 C 指数分别为 0.664 和 0.728。Kaplan-Meier生存分析表明,Nomo评分大于128与房颤复发风险较高有关:结论:血液动力学参数可为预测导管消融术后房颤复发提供有价值的见解。我们的研究根据超声心动图血流动力学参数成功开发了一种可靠的提名图,用于估计 NVAF 患者导管消融术后房颤复发的风险。
{"title":"Development and validation of a predictive model for atrial fibrillation recurrence post-catheter ablation in non-valvular atrial fibrillation patients based on hemodynamic parameters.","authors":"Decai Zeng, Shuai Chang, Xiaofeng Zhang, Yanfen Zhong, Yongzhi Cai, Tongtong Huang, Ji Wu","doi":"10.1016/j.hrthm.2024.08.058","DOIUrl":"https://doi.org/10.1016/j.hrthm.2024.08.058","url":null,"abstract":"<p><strong>Background: </strong>The influence of hemodynamic parameters on the recurrence of atrial fibrillation (AF) following catheter ablation is not well known, and it remains unclear whether a nomogram combining risk factors and hemodynamic parameters improves prediction accuracy.</p><p><strong>Objective: </strong>This study aimed to develop a nomogram based on echocardiographic hemodynamic parameters for predicting AF recurrence following catheter ablation in non-valvular atrial fibrillation (NVAF).</p><p><strong>Methods: </strong>A total of 380 consecutive NVAF patients undergoing AF catheter ablation treatment were prospectively collected. Patients were divided into training and validation cohorts at a 7:3 ratio. The follow-up duration averaged 9 months with a median of 12 months, during which 132 patients (34.7%) experienced a recurrence of AF.</p><p><strong>Results: </strong>LASSO regression and Cox regression analyses identified four significant predictors of AF recurrence: persistent AF (HR=1.63, 95% CI=1.02∼2.61, P=0.041), the systolic/diastolic (S/D) ratio (HR=0.50, 95% CI=0.30∼0.84, P=0.009), left atrial acceleration factor α (HR=1.31, 95% CI=1.02∼1.68, P=0.032), and left atrial appendage peak emptying flow velocity (HR=0.98, 95% CI=0.97∼0.99, P=0.004). Based on these four variables, a predictive nomogram was constructed. The nomogram demonstrated C-indexes of 0.664 and 0.728 for predicting 1-year and 2-year AF recurrence, respectively, in the validation cohort. The Kaplan-Meier survival analysis indicated that a Nomo-score greater than 128 was associated with a higher risk of AF recurrence.</p><p><strong>Conclusion: </strong>Hemodynamic parameters may offer valuable insight in predicting AF recurrence following catheter ablation. Our study successfully developed a reliable nomogram based on echocardiographic hemodynamic parameters to estimate the risk of AF recurrence after catheter ablation in NVAF patients.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of Different Left Bundle Branch Pacing Sites and Clinical Outcomes in Heart Failure Patients. 不同左束支起搏点与心衰患者临床疗效的关系
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-02 DOI: 10.1016/j.hrthm.2024.08.059
Wen Liu, Zibire Fulati, Fangyan Tian, Nuo Xu, Yufei Cheng, Yingjie Zhao, Haiyan Chen, Xianhong Shu

Backgroud: Left bundle branch pacing (LBBP) is a novel physiological pacing modality. However, whether it delivers comparable efficacy with different capture sites in heart failure (HF) patients remains unclear.

Objective: This study aims to assess the association between different pacing sites and the response of LBBP .

Methods: Forty-three consecutive HF patients , referred for successful LBBP implantation, were prospectively recruited in this study. Patients were assigned to 3 subgroups according to the paced QRS complex morphology (left bundle branch trunk pacing (LBTP), left posterior fascicular pacing (LPFP) or left anterior fascicular pacing (LAFP) groups). Echocardiograms, electrocardiograms were recorded and analyzed at baseline and 6-month follow-up.

Results: The response rate was 95.0%, 88.2%, 83.3% in LBTP, LPFP and LAFP groups, respectively. All subgroups were efficient in narrowing QRS complex(ΔQRS: 62.4±10.4 ms, 54.7±14.2ms, 58.2±14.5ms) and improving cardiac function (ΔLVEF: 25.7±8.1%, 15.3±8.1%, 18.8±4.4%). Compared with left fascicle pacing(LFP), LBTP resulted in longer LVAT (76.5±10.2ms vs 82.3±6.5ms; P=0.037) , shorter QRSid (128.0±6.0ms vs 113.3±5.2ms; P<0.0001),along with better improvement in septal systolic longitudinal strain(P=0.007) and lateral-septal myocardial loading inhomogeneity (P=0.036). Linear regression analysis further revealed LBB capture sites was strongly associated with the improvement of peak strain dispersion (PSD) (model R2 = 0.586, P =0.042) and LVEF (model R2 = 0.425, P <0.0001).

Conclusions: Different LBB capture sites led to subtle difference in mechanical synchrony , which may in-turn affect LVEF improvement in HF patients.

背景:左束支起搏(LBBP)是一种新型的生理起搏方式。然而,在心力衰竭(HF)患者中,不同的捕获部位是否具有可比疗效仍不清楚:本研究旨在评估不同起搏部位与 LBBP 反应之间的关联:本研究前瞻性地招募了43名成功植入LBBP的连续心衰患者。根据起搏QRS波群形态将患者分为3个亚组(左束支干起搏组(LBTP)、左后筋膜起搏组(LPFP)或左前筋膜起搏组(LAFP))。记录并分析了基线和6个月随访时的超声心动图和心电图:结果:LBTP、LPFP 和 LAFP 组的响应率分别为 95.0%、88.2% 和 83.3%。所有亚组在缩小 QRS 波群(ΔQRS:62.4±10.4 ms、54.7±14.2 ms、58.2±14.5 ms)和改善心功能(ΔLVEF:25.7±8.1%、15.3±8.1%、18.8±4.4%)方面均有效。与左束起搏(LFP)相比,LBTP 使 LVAT 更长(76.5±10.2ms vs 82.3±6.5ms;P=0.037),QRSid 更短(128.0±6.0ms vs 113.3±5.2ms;P<0.0001),室间隔收缩期纵向应变(P=0.007)和侧隔心肌负荷不均匀性(P=0.036)得到更好的改善。线性回归分析进一步显示,LBB捕获部位与峰值应变弥散(PSD)(模型R2=0.586,P=0.042)和LVEF(模型R2=0.425,P 结论)的改善密切相关:不同的 LBB 捕获部位会导致机械同步性的细微差别,进而影响心房颤动患者 LVEF 的改善。
{"title":"Relationship of Different Left Bundle Branch Pacing Sites and Clinical Outcomes in Heart Failure Patients.","authors":"Wen Liu, Zibire Fulati, Fangyan Tian, Nuo Xu, Yufei Cheng, Yingjie Zhao, Haiyan Chen, Xianhong Shu","doi":"10.1016/j.hrthm.2024.08.059","DOIUrl":"https://doi.org/10.1016/j.hrthm.2024.08.059","url":null,"abstract":"<p><strong>Backgroud: </strong>Left bundle branch pacing (LBBP) is a novel physiological pacing modality. However, whether it delivers comparable efficacy with different capture sites in heart failure (HF) patients remains unclear.</p><p><strong>Objective: </strong>This study aims to assess the association between different pacing sites and the response of LBBP .</p><p><strong>Methods: </strong>Forty-three consecutive HF patients , referred for successful LBBP implantation, were prospectively recruited in this study. Patients were assigned to 3 subgroups according to the paced QRS complex morphology (left bundle branch trunk pacing (LBTP), left posterior fascicular pacing (LPFP) or left anterior fascicular pacing (LAFP) groups). Echocardiograms, electrocardiograms were recorded and analyzed at baseline and 6-month follow-up.</p><p><strong>Results: </strong>The response rate was 95.0%, 88.2%, 83.3% in LBTP, LPFP and LAFP groups, respectively. All subgroups were efficient in narrowing QRS complex(ΔQRS: 62.4±10.4 ms, 54.7±14.2ms, 58.2±14.5ms) and improving cardiac function (ΔLVEF: 25.7±8.1%, 15.3±8.1%, 18.8±4.4%). Compared with left fascicle pacing(LFP), LBTP resulted in longer LVAT (76.5±10.2ms vs 82.3±6.5ms; P=0.037) , shorter QRSid (128.0±6.0ms vs 113.3±5.2ms; P<0.0001),along with better improvement in septal systolic longitudinal strain(P=0.007) and lateral-septal myocardial loading inhomogeneity (P=0.036). Linear regression analysis further revealed LBB capture sites was strongly associated with the improvement of peak strain dispersion (PSD) (model R2 = 0.586, P =0.042) and LVEF (model R2 = 0.425, P <0.0001).</p><p><strong>Conclusions: </strong>Different LBB capture sites led to subtle difference in mechanical synchrony , which may in-turn affect LVEF improvement in HF patients.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ID: 4121045 A Wearable-Derived Metadata Model For The Temporal Prediction Of AF Recurrence ID: 4121045 用于房颤复发时间预测的可穿戴元数据模型
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hrthm.2024.07.086
{"title":"ID: 4121045 A Wearable-Derived Metadata Model For The Temporal Prediction Of AF Recurrence","authors":"","doi":"10.1016/j.hrthm.2024.07.086","DOIUrl":"10.1016/j.hrthm.2024.07.086","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ID: 4149546 Coordinating Options for Neurovascular patients Needing Electrophysiology Consults and Treatments- Experiences and Processes ID: 4149546 协调需要电生理学咨询和治疗的神经血管患者的选择--经验和流程
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hrthm.2024.07.076
{"title":"ID: 4149546 Coordinating Options for Neurovascular patients Needing Electrophysiology Consults and Treatments- Experiences and Processes","authors":"","doi":"10.1016/j.hrthm.2024.07.076","DOIUrl":"10.1016/j.hrthm.2024.07.076","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ID: 4113106 Identifying Acute Myocardial Infarction Early: Clinical Utility of a 12-Lead Electrocardiogram Synthesized from a Single Touch of a Wrist-Worn Device ID: 4113106 早期识别急性心肌梗死:通过单次触摸腕戴式设备合成的 12 导联心电图的临床实用性
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hrthm.2024.07.055
{"title":"ID: 4113106 Identifying Acute Myocardial Infarction Early: Clinical Utility of a 12-Lead Electrocardiogram Synthesized from a Single Touch of a Wrist-Worn Device","authors":"","doi":"10.1016/j.hrthm.2024.07.055","DOIUrl":"10.1016/j.hrthm.2024.07.055","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ID: 4118529 Initial Experience with a Novel Augmented Reality System for use During Catheter Ablation ID: 4118529 在导管消融过程中使用新型增强现实系统的初步体验
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hrthm.2024.07.040
{"title":"ID: 4118529 Initial Experience with a Novel Augmented Reality System for use During Catheter Ablation","authors":"","doi":"10.1016/j.hrthm.2024.07.040","DOIUrl":"10.1016/j.hrthm.2024.07.040","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection ID: 4121707 信号质量评估对自动心室异位搏动检测的益处
IF 5.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hrthm.2024.07.087
{"title":"ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection","authors":"","doi":"10.1016/j.hrthm.2024.07.087","DOIUrl":"10.1016/j.hrthm.2024.07.087","url":null,"abstract":"","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":null,"pages":null},"PeriodicalIF":5.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Heart rhythm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1